biote Corp (BTMD) stock price

biote Corp (BTMD) is a Healthcare · Medical Care Facilities company listed on NASDAQ. Price $1.37 (+1.48%), Market cap $0.07B, P/E ratio 4.66, 52-week low–high $1.30 ~ $4.55.

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other adminis

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for biote Corp are updated in real time on BlackAll Trade.

biote Corp financial summary

Analyst outlook

Key ratios · profitability · growth

Frequently asked questions

What is the current biote Corp (BTMD) stock price?

biote Corp trades at $1.37 (+1.48%). Real-time quotes and charts are available on BlackAll Trade.

What is the biote Corp (BTMD) market cap?

biote Corp has a market cap of about $0.07B. Its P/E ratio is 4.66.

What does biote Corp (BTMD) do?

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pe